2023 Complication Medical Patient-Centered 
Medical Xpress
MARCH 17, 2023
A study evaluating opioid prescribing patterns and postoperative complications in patients undergoing third molar removal treated with and without liposomal bupivacaine was presented at the 52nd Annual Meeting & Exhibition of the AADOCR, held in conjunction with the 47th Annual Meeting of the CADR.
Physician's Weekly
JUNE 19, 2025
When Alyne Diamond fell off a horse in August 2023 and broke her back, her employer-based health plan through UnitedHealthcare covered her emergency care in Aspen, Colorado. If people in these groups don’t sign up for Medicare when they become eligible, they can find themselves responsible for all their medical bills for years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
DECEMBER 13, 2023
Sasinowski — On December 12, 2023, FDA announced the creation of a new advisory committee specifically for treatments for genetic metabolic diseases, the Genetic Metabolic Diseases Advisory Committee, or “GeMDAC.” Drug development for these conditions has unique and complex challenges, therefore few treatments are available to patients.”
PEMBlog
AUGUST 20, 2024
While ECPR shows promise in improving survival rates, particularly in pediatric patients with conditions like congenital heart disease, it is resource-intensive and carries significant risks. 2023; 187:109792. Now, some centers are using 15 minutes in their guidelines, but 30 is what I’m familiar with. Am Heart J.
PEMBlog
APRIL 20, 2023
A special thanks to Dr. Cristina Tarango, director of the Hemophilia Treatment Center at Cincinnati Children’s and Lisa Littner, Project Manager at Cincinnati Children’s who helped me research and write this post. How to know if a patient is on it? Patients on emicizumab will have it listed on their medication list.
FDA Law Blog
FEBRUARY 29, 2024
As FDA explains on its website (which includes lists— here and here —of the more than 300 Accelerated Approvals (and withdrawals)): The FDA instituted its Accelerated Approval Program to allow for earlier approval of drugs that treat serious conditions, and fill an unmet medical need based on a surrogate endpoint.
Annals of Family Medicine
NOVEMBER 20, 2024
Objective: 1) Demonstrate the feasibility of collecting data from prescription drug monitoring programs (PDMPs) for population health reporting, 2) analyze trends in PDMP and electronic health record patient data relative to CDC guidelines and 3) identify use of patient-centered measures for pain management in primary care.
Expert insights. Personalized for you.
74 
Let's personalize your content